Researchers estimate the total economic impact of respiratory syncytial virus (RSV) to be around £80 million each year, based on a rapid evidence assessment to model the disease's wider societal and economic burden in the UK.
In 2019, absenteeism and presenteeism cost the UK economy almost £92 billion because of ill-health, but the economic burden specific to seasonal influenza is not well understood. Researchers are exploring the indirect economic and societal burden of seasonal influenza, including its effects on the UK healthcare system.
Poor indoor climate can result in a higher risk of health and wellbeing disorders, especially in children, the elderly and those with existing health conditions. Exposure of Europeans to damp, mould, and insufficient daylight in residential buildings could cost €53 billion over the next 30 years.
The AMR Industry Alliance brings together over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations in the fight against AMR. RAND Europe assessed the progress of AMRIA members in contributing to tackling AMR and found they are making a difference on diverse fronts.
Researchers assessed the feasibility for expanding longitudinal data collection on gambling in the UK. They provide six distinct options, each with their own strengths and drawbacks, for consideration by the charity Action Against Gambling Harms.
Although EU member states are generally compliant with national rules on smoke-free environments and tobacco-related advertising, some areas require closer scrutiny, including protecting children from the harms of smoking.
Electronic health records (EHR) data could greatly help infectious disease surveillance, but their use varies across Europe. Researchers mapped EHR use to assess the feasibility of using EHR data for infectious disease surveillance.
The new “traffic light” coalition in Germany recently agreed to regulate the sale of cannabis to adults for recreational purposes in licensed shops. International experience has shown that great care is needed in how cannabis policy is shaped.
Researchers examined the availability of point-of-care testing (POCT) devices to diagnose 56 communicable diseases and related health issues under EU surveillance — not including COVID-19 — and mapped trends in the use of POCT in Europe.
To prepare for the implementation of a pilot scheme to pay for cancer drugs based on achieved outcomes, researchers addressed issues identified in the first phase of research, such as the quality and completeness of real-world data on key patient outcomes.
Most research on antimicrobial resistance (AMR) focuses on its effects on communicable diseases. But AMR can result in a wide variety of negative outcomes for patients with non-communicable health conditions and/or who are exposed to certain healthcare services.
Australia is at risk of a fentanyl problem, but it is better prepared than North America. If the country can make the same kind of concerted effort it did to keep COVID-19 at bay, that could save thousands of lives.
Vaccine nationalism could prolong the pandemic and lead to preventable deaths. If some countries don't receive timely access to vaccines, then the virus will continue to spread in some populations, mutate further, and potentially render existing vaccines less effective.
Complex evaluations at multiple levels are gathering evidence for Guy’s and St Thomas’ Charity on societal determinants of health such as housing, debt, racism and labour markets. The findings will inform policy to help those most at risk of developing long-term conditions.
Without a vaccine, the worldwide economic impact of COVID-19 could be $3.4 trillion a year. But even when a vaccine is available, an unequal allocation of COVID-19 vaccines could cost the global economy up to $1.2 trillion a year in GDP.